Search results
Results from the WOW.Com Content Network
C-Reactive Protein (CRP) - Increased CRP levels are found in inflammatory conditions including: bacterial infection, rheumatic fever, active arthritis, myocardial infarction, malignancies and in the post-operative state.
hs-CRP (mg/L) Risk According to AHA/CDC Guidelines <1.0: Lower relative cardiovascular risk. 1.0-3.0: Average relative cardiovascular risk. 3.1-10.0: Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0
C-reactive protein (CRP) is a nonspecific acute-phase protein produced by the liver in response to tissue injury, infection, and inflammation. CRP levels rise as much as 1,000-fold after an acute event; these high levels can be used to diagnose and monitor acute inflammatory states.
In-home collection may be available in your area for purchase through Quest Mobile Clinical Significance Cardio IQ® hs-CRP - Useful in predicting risk of cardiovascular disease.
Sed Rate by Modified Westergren - Useful in differentiating inflammatory and neoplastic diseases and as an index of disease severity. CRP is also useful in monitoring inflammatory disease states.
Welcome to the Quest Diagnostics Test Directory Search for tests and educational resources with confidence. Filter by specialty or test category, and compare tests side-by-side.
The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.
The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.
However, the standard lipid panel alone does not provide a complete assessment of absolute risk of CVD. Adding advanced CVD markers (ion mobility, apob, lp(a), hs crp and lppla2) in addition to the lipid panel will improve assessment of the CVD risk.
Rheumatoid Arthritis Classification Criteria include CCP IgG Antibody, rheumatoid factor, C-reactive protein and erythrocyte sedimentation rate (ESR). Approximately 70% of patients with Rheumatoid Arthritis are positive for Anti-CCP IgG, while only about 2% of random blood donors and disease controls subjects are positive.